|
|
|
Insider
Information: |
Horn Patrick Taylor |
Relationship: |
Chief Medical Officer |
City: |
Watertown |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
22,355 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$547,833 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
22,355 |
|
|
Total
Value |
$547,833 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Tetraphase Pharmaceuticals Inc |
TTPH |
Chief Medical Officer |
2017-06-13 |
10,000 |
2015-05-13 |
0 |
Premium* |
|
Albireo Pharma Inc |
ALBO |
Chief Medical Officer |
2021-10-22 |
12,355 |
2019-01-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALBO |
Albireo Pharma Inc |
Chief Medical Officer |
|
2021-10-22 |
4 |
AS |
$28.83 |
$2,739 |
D/D |
(95) |
12,355 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Medical Officer |
|
2021-07-22 |
4 |
AS |
$34.13 |
$3,072 |
D/D |
(90) |
12,450 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Medical Officer |
|
2021-04-22 |
4 |
AS |
$31.75 |
$2,858 |
D/D |
(90) |
11,893 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Medical Officer |
|
2021-01-22 |
4 |
AS |
$34.62 |
$3,808 |
D/D |
(110) |
9,825 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Medical Officer |
|
2021-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
5,500 |
9,935 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Medical Officer |
|
2020-10-22 |
4 |
AS |
$34.55 |
$3,075 |
D/D |
(89) |
4,285 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Medical Officer |
|
2020-07-22 |
4 |
AS |
$25.80 |
$2,348 |
D/D |
(91) |
4,374 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Medical Officer |
|
2020-04-22 |
4 |
AS |
$17.64 |
$1,623 |
D/D |
(92) |
4,465 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Medical Officer |
|
2020-01-22 |
4 |
AS |
$24.29 |
$10,760 |
D/D |
(443) |
4,557 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Medical Officer |
|
2019-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Chief Medical Officer |
|
2017-06-13 |
4 |
OE |
$2.03 |
$20,300 |
D/D |
10,000 |
10,000 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Chief Medical Officer |
|
2015-08-13 |
4 |
AS |
$44.69 |
$446,900 |
D/D |
(10,000) |
0 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Chief Medical Officer |
|
2015-08-13 |
4 |
OE |
$2.03 |
$20,300 |
D/D |
10,000 |
10,000 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Chief Medical Officer |
|
2015-07-13 |
4 |
AS |
$48.93 |
$489,300 |
D/D |
(10,000) |
0 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Chief Medical Officer |
|
2015-07-13 |
4 |
OE |
$2.03 |
$20,300 |
D/D |
10,000 |
10,000 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Chief Medical Officer |
|
2015-06-12 |
4 |
AS |
$41.72 |
$417,200 |
D/D |
(10,000) |
0 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Chief Medical Officer |
|
2015-06-12 |
4 |
OE |
$2.03 |
$20,300 |
D/D |
10,000 |
10,000 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Chief Medical Officer |
|
2015-05-13 |
4 |
AS |
$39.88 |
$398,800 |
D/D |
(10,000) |
0 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Chief Medical Officer |
|
2015-05-13 |
4 |
OE |
$2.03 |
$20,300 |
D/D |
10,000 |
10,000 |
0 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|